Evidence map›Paper›PMID 37207093›Full record

ArticleRSC advances2023

Biobased epoxy reactive diluents prepared from monophenol derivatives: effect on viscosity and glass transition temperature of epoxy resins.

Samuel Malburet, Hugo Bertrand, Cécile Richard, Colette Lacabanne, Eric Dantras, Alain Graillot

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 19 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Samuel MalburetSPECIFIC POLYMERS 150 Avenue des Cocardières 34160 Castries France samuel.malburet@specificpolymers.fr.ORCID https://orcid.org/0000-0002-4224-9520
Hugo BertrandSPECIFIC POLYMERS 150 Avenue des Cocardières 34160 Castries France samuel.malburet@specificpolymers.fr.
Cécile RichardSPECIFIC POLYMERS 150 Avenue des Cocardières 34160 Castries France samuel.malburet@specificpolymers.fr.
Colette LacabanneCIRIMAT, Université Toulouse III - Paul Sabatier 118 Route de Narbonne 31062 Toulouse Cedex 09 France.
Eric DantrasCIRIMAT, Université Toulouse III - Paul Sabatier 118 Route de Narbonne 31062 Toulouse Cedex 09 France.
Alain GraillotSPECIFIC POLYMERS 150 Avenue des Cocardières 34160 Castries France samuel.malburet@specificpolymers.fr.ORCID https://orcid.org/0000-0001-5970-5687
Université Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of reactive diluents is undeniably of paramount importance to develop epoxy resins which would meet more demanding and restrictive processes and applications in terms of viscosity and glass transition temperature. In the context of developing resins with low carbon impacts, 3 natural phenols namely carvacrol, guaiacol and thymol were selected and converted into monofunctional epoxies using a general glycidylation procedure. Without advanced purification, the developed liquid-state epoxies showed very low viscosities of 16 cPs to 55 cPs at 20 °C, which could be further reduced to 12 cPs at 20 °C when purification by distillation is applied. The dilution effect of each reactive diluent on DGEBA's viscosity was also assessed for concentrations ranging from 5 to 20 wt% and compared to commercial and formulated DGEBA-based resin analogues. Interestingly, the use of these diluents reduced the initial viscosity of DGEBA by a factor of ten while maintaining glass transition temperatures above 90 °C. This article provides compelling evidence of the possibility of developing new sustainable epoxy resins with characteristics and properties that can be fine-tuned by only adjusting the reactive diluent concentration.

Identifiers

PMID37207093
PMCPMC10189243
OpenAlexW4377007837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.